| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Product Officer | President - Molecular Sol | EVP & Amp; Bu Lead - Molecular
1 company
Kathleen Gallagher Weber last filed a Form 4 in March 2025, as Chief Product Officer at OSUR. Kathleen Gallagher Weber's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 391,206 shares of OSUR. The OSUR filings lean toward selling, a net 34,129 shares.
Kathleen Gallagher Weber has 16 Form 4 filings on record from February 2019 to March 2025, all as Chief Product Officer at Orasure Technologies (OSUR), 2019–2025.
The 52 reported transactions were 31 tax withholdings, 18 stock awards, 2 open-market sales and 1 option exercise.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $312K.
The largest open-market sale was 24,129 shares of OSUR at an average $8.05 on December 19, 2023, about $194K. Twelve months later OSUR was down 53%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.